secwatch.observer — SEC 8-K summary
======================================

Issuer:     SOLIGENIX, INC. (SNGX)
CIK:        0000812796
Form:       8-K
Filed at:   2025-09-29T23:59:59+00:00
Accession:  0001104659-25-094507
Event type: other_material
Sentiment:  neutral
Materiality: 0.75
Item codes: 1.01, 8.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Soligenix closes $7.5M public offering; cash runway extended through 2026
-------------------------------------------------------------------------

- Gross proceeds of ~$7.5M from sale of 5,555,560 units at $1.35/unit, each consisting of one share (or pre-funded warrant) and one warrant.
- Warrants exercisable at $1.35 per share for five years from issuance; 1,162,064 existing warrants amended to same terms.
- Cash runway now extends through end of 2026 to fund key clinical/commercial inflection points.
- Net proceeds to fund R&D, commercialization, working capital and general corporate purposes.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/812796/000110465925094507/0001104659-25-094507-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/812796/000110465925094507/sngx-20250925x8k.htm
  HTML page:      https://secwatch.observer/filing/0001104659-25-094507

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer